Changes to be made to the Prescribed List (Jersey) as at 1 January 2008.

Information about the publication of Ministerial Decisions

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision
providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision (14/12/2007) regarding: Changes to be made to the Prescribed List (Jersey) as at 1 January 2008.

Decision Reference: MD-S-2007-0084
Decision Summary Title :	Prescribed List (Jersey) 1 January 2008		Date of Decision Summary:	28/11/07
Decision Summary Author:	R. Goulding Policy Principal		Decision Summary: Public or Exempt?	Public
Type of Report: Oral or Written?	Written		Person Giving Oral Report:
Written Report Title :	Changes to be made to the Prescribed List (Jersey) as at 1 January 2008		Date of Written Report:	28/11/07
Written Report Author:	R. Goulding Policy Principal		Written Report : Public or Exempt?	Public
Subject: Changes to be made to the Prescribed List (Jersey) as at 1 January 2008
Decision(s): The Minister approved the undermentioned changes to the Prescribed List (Jersey) as recommended by the Pharmaceutical Benefits Advisory Committee from the meeting held on the 20 November 2007. To be included: i. Green classification Lymecycline capsule 408mg Conjugated oestrogens (equine) tablet 300mcg Tiotropium solution for inhalation 2.5mcg Diabact UBT kit. Acarbose 100mg Amantadine hydrochloride syrup 50mg/5ml Carbamazepine suppositories 125mg, 250mg Dexamethasone Minims 0.1% single use eye drops Propylthiouracil tablets 50mg Ranitidine oral solution 75mg/5ml Risedronate sodium tablet 35mg Verapamil S/R tablets 120mg ii. Amber classification Eplerenone tablet 25mg, 50mg (*Inspra – Pfizer) Pramipexole 700mcg Donepezil tablet 10mg Levodopa/carbidopa/entacapone tablets 50mg/12.5mg/200mg; 100mg/25mg/200mg; 150mg/37.5mg/200mg To be included on the dental list Sodium fluoride toothpaste 0.2% w/w Clindamycin 150mg To give notice that the following items will be deleted from the Prescribed List from 1 January 2008 Pylobactell. Co-proxomol Sodium Chloride Infusion 0.18%- 500ml; 1.8% - 500ml; 5% -500ml Trichloroacetic and salicylic Acid paste Weak Iodine solution Digoxin injection 100mcg/ml Calcium syrup 325mg Chlorhexidine with cetrimide Collodion flexible solution Heparanised saline injection 50 iu/ml Levobupivacaine/Adrenaline injection 0.5 %/1ml in 200 000; 1%/1 in 200,000 Lidocaine preservative free injection 0.5% - 20 ml Lidocaine aerosol spray 10% Midazolam buccal solution 10mg/ml Potassium chloride/Dextrose infusion 0.6%/5% 500ml Potassium chloride/Dextrose/sodium chloride infusion 0.15%/4%/0.18% -500ml; 1L. Potassium chloride/Dextrose/sodium chloride infusion 0.3%/4%/0.18% - 500ml; 1L. Potassium chloride/Sodium chloride infusion 0.3%/5% - 1L Potassium chloride/Sodium chloride infusion 0.6%/0.9%, 1L Prilocaine preservative free injection 0.5% Prilocaine/octapressin injection 3%/0.03% units To give notice that the following items will be deleted from the Prescribed List from 1 June 2008 Atorvastatin 10mg; 20mg;40mg To give notice of the following amendments and clarifications to current list Please refer to attached list
Reason(s) for Decision: The Pharmaceutical Benefits Advisory Committee met on 20 November 2007 and provided the Department with the recommended changes to the Prescribed List (Jersey) to become effective from 1 January 2008. The changes include omissions and clarifications to the single Island formulary that was implemented in October 2007.
Resource Implications: The single Island formulary will result in an additional annual cost of £1.3 million (approximate) cost to the Health Insurance fund and the recommendations are part of this cost. The Fund has sufficient resources
Action required: The Minister is asked to approve the recommendations made by the Pharmaceutical Benefits Advisory Committee
Signature:		Position:
Date Signed:		Date of Decision (If different from Date Signed):